Fundz

Who to call at Nurix Therapeutics, and when

Fundz watches for the moments Nurix Therapeutics starts buying, and tells you who to reach.

  • An alert the day Nurix Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nurix Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Nurix Therapeutics Partners with Roche to Develop Bexobrutideg for B-Cell Malignancies

Jun 08, 2026

Contract Type

partnership

San FranciscoOtherBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Nurix Therapeutics has announced a global collaboration with Roche to develop bexobrutideg, a novel therapy for B-cell malignancies. The partnership includes a robust clinical development plan with a total potential value of $2.3 billion, incorporating both hematology and plans for trials in neurology and immunology.

Company Information

Company

Nurix Therapeutics

Location

San Francisco, California, United States

About

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases. The company is focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases.

Related People

Paula
Likely contact at this company
••••••••@••••••••

See Paula's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Nurix Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Nurix Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.